It’s a showpiece drug that has the potential to end a disease that kills half a million African children a year. Yet even before it wins a license, the world’s first malaria vaccine has lost some of its sheen. Backed by billionaire philanthropist Bill Gates and developed by GlaxoSmithKline, the vaccine — called RTS,S or […]

Scientists have discovered a new anti-malarial compound that could treat patients with a single $1 dose, including those with strains of the mosquito-borne disease that are resistant to current drugs. Although it is still years from reaching the market, results from tests conducted on human blood in the laboratory and in live mice suggest it […]